Cargando…

Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid

INTRODUCTION: Basal cell carcinoma (BCC) is the most common malignant neoplasm of the eyelids and surrounding structures, usually developing in the area of the lower lid and medial canthus. Invasive forms of BCC are connected with a high risk of recurrence, often due to incomplete excision of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Iljin, Aleksandra, Zieliński, Tomasz, Antoszewski, Bogusław, Sporny, Stanisław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793053/
https://www.ncbi.nlm.nih.gov/pubmed/26985178
http://dx.doi.org/10.5114/pdia.2015.48039
_version_ 1782421334127542272
author Iljin, Aleksandra
Zieliński, Tomasz
Antoszewski, Bogusław
Sporny, Stanisław
author_facet Iljin, Aleksandra
Zieliński, Tomasz
Antoszewski, Bogusław
Sporny, Stanisław
author_sort Iljin, Aleksandra
collection PubMed
description INTRODUCTION: Basal cell carcinoma (BCC) is the most common malignant neoplasm of the eyelids and surrounding structures, usually developing in the area of the lower lid and medial canthus. Invasive forms of BCC are connected with a high risk of recurrence, often due to incomplete excision of these lesions. AIM: Clinical and pathological analysis of recurrent BCCs of the eyelids and surrounding structures. MATERIAL AND METHODS: We present clinical and pathological analysis including immunohistochemical reaction to Ki-67 antigen of 19 patients (11 women, 8 men) operated for recurrent BCCs of the eyelids in 2000–2012. RESULTS: In most cases, recurrences were present on the lower lid and in the medial canthus. In 15 patients the histopathological type did not change and in 4 cases it transformed into more invasive forms. The values of Ki-67 index for primary BCCs ranged between 1% and 20%, and for relapsing lesions between 11% and 48%. CONCLUSIONS: Proper clinical and pathological evaluation to determine the risk of relapse in BCCs of the eyelids and surrounding structures should include the analysis of prognostic factors, in particular location and size, histopathological type and radicalness of surgical treatment of primary BCCs. Clinical and pathological analysis of patients with recurrent BCC of the eyelids and surrounding structures should be combined with the evaluation of proliferation index Ki-67, which is essential for prognosis and choice of the appropriate therapeutic method.
format Online
Article
Text
id pubmed-4793053
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-47930532016-03-16 Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid Iljin, Aleksandra Zieliński, Tomasz Antoszewski, Bogusław Sporny, Stanisław Postepy Dermatol Alergol Original Paper INTRODUCTION: Basal cell carcinoma (BCC) is the most common malignant neoplasm of the eyelids and surrounding structures, usually developing in the area of the lower lid and medial canthus. Invasive forms of BCC are connected with a high risk of recurrence, often due to incomplete excision of these lesions. AIM: Clinical and pathological analysis of recurrent BCCs of the eyelids and surrounding structures. MATERIAL AND METHODS: We present clinical and pathological analysis including immunohistochemical reaction to Ki-67 antigen of 19 patients (11 women, 8 men) operated for recurrent BCCs of the eyelids in 2000–2012. RESULTS: In most cases, recurrences were present on the lower lid and in the medial canthus. In 15 patients the histopathological type did not change and in 4 cases it transformed into more invasive forms. The values of Ki-67 index for primary BCCs ranged between 1% and 20%, and for relapsing lesions between 11% and 48%. CONCLUSIONS: Proper clinical and pathological evaluation to determine the risk of relapse in BCCs of the eyelids and surrounding structures should include the analysis of prognostic factors, in particular location and size, histopathological type and radicalness of surgical treatment of primary BCCs. Clinical and pathological analysis of patients with recurrent BCC of the eyelids and surrounding structures should be combined with the evaluation of proliferation index Ki-67, which is essential for prognosis and choice of the appropriate therapeutic method. Termedia Publishing House 2016-02-29 2016-02 /pmc/articles/PMC4793053/ /pubmed/26985178 http://dx.doi.org/10.5114/pdia.2015.48039 Text en Copyright © 2016 Termedia http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Iljin, Aleksandra
Zieliński, Tomasz
Antoszewski, Bogusław
Sporny, Stanisław
Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid
title Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid
title_full Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid
title_fullStr Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid
title_full_unstemmed Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid
title_short Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid
title_sort clinicopathological analysis of recurrent basal cell carcinoma of the eyelid
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793053/
https://www.ncbi.nlm.nih.gov/pubmed/26985178
http://dx.doi.org/10.5114/pdia.2015.48039
work_keys_str_mv AT iljinaleksandra clinicopathologicalanalysisofrecurrentbasalcellcarcinomaoftheeyelid
AT zielinskitomasz clinicopathologicalanalysisofrecurrentbasalcellcarcinomaoftheeyelid
AT antoszewskibogusław clinicopathologicalanalysisofrecurrentbasalcellcarcinomaoftheeyelid
AT spornystanisław clinicopathologicalanalysisofrecurrentbasalcellcarcinomaoftheeyelid